Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer

Katherine A. Leehy, Tarah M Regan Anderson, Andrea R. Daniel, Carol A Lange, Julie H Ostrander

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Steroid hormone receptors (SRs) are heavily posttranslationally modified by the reversible addition of a variety of molecular moieties, including phosphorylation, acetylation, methylation, SUMOylation, and ubiquitination. These rapid and dynamic modifications may be combinatorial and interact (i.e. may be sequential, complement, or oppose each other), creating a vast array of uniquely modified receptor subspecies that allow for diverse receptor behaviors that enable highly sensitive and context-dependent hormone action. For example, in response to hormone or growth factor membrane-initiated signaling events, posttranslational modifications (PTMs) to SRs alter protein–protein interactions that govern the complex process of promoter or gene-set selection coupled to transcriptional repression or activation. Unique phosphorylation events allow SRs to associate or disassociate with specific cofactors that may include pioneer factors and other tethering partners, which specify the resulting transcriptome and ultimately change cell fate. The impact of PTMs on SR action is particularly profound in the context of breast tumorigenesis, in which frequent alterations in growth factor-initiated signaling pathways occur early and act as drivers of breast cancer progression toward endocrine resistance. In this article, with primary focus on breast cancer relevance, we review the mechanisms by which PTMs, including reversible phosphorylation events, regulate the closely related SRs, glucocorticoid receptor and progesterone receptor, allowing for precise biological responses to ever-changing hormonal stimuli.

Original languageEnglish (US)
Pages (from-to)R99-R114
JournalJournal of Molecular Endocrinology
Volume56
Issue number3
DOIs
StatePublished - Apr 1 2016

Fingerprint

Glucocorticoid Receptors
Progesterone Receptors
Steroid Receptors
Hormones
Breast Neoplasms
Post Translational Protein Processing
Phosphorylation
Intercellular Signaling Peptides and Proteins
Sumoylation
Ubiquitination
Acetylation
Transcriptome
Methylation
Carcinogenesis
Breast
Membranes
Genes

Keywords

  • Breast cancer
  • Glucocorticoid receptor
  • Modification
  • Phosphorylation
  • Posttranslational
  • Progesterone receptor
  • Protein kinases
  • Signal transduction
  • Steroid hormones

Cite this

Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. / Leehy, Katherine A.; Regan Anderson, Tarah M; Daniel, Andrea R.; Lange, Carol A; Ostrander, Julie H.

In: Journal of Molecular Endocrinology, Vol. 56, No. 3, 01.04.2016, p. R99-R114.

Research output: Contribution to journalReview article

Leehy, Katherine A. ; Regan Anderson, Tarah M ; Daniel, Andrea R. ; Lange, Carol A ; Ostrander, Julie H. / Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. In: Journal of Molecular Endocrinology. 2016 ; Vol. 56, No. 3. pp. R99-R114.
@article{39295c62d9274562be32e3455dd8d518,
title = "Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer",
abstract = "Steroid hormone receptors (SRs) are heavily posttranslationally modified by the reversible addition of a variety of molecular moieties, including phosphorylation, acetylation, methylation, SUMOylation, and ubiquitination. These rapid and dynamic modifications may be combinatorial and interact (i.e. may be sequential, complement, or oppose each other), creating a vast array of uniquely modified receptor subspecies that allow for diverse receptor behaviors that enable highly sensitive and context-dependent hormone action. For example, in response to hormone or growth factor membrane-initiated signaling events, posttranslational modifications (PTMs) to SRs alter protein–protein interactions that govern the complex process of promoter or gene-set selection coupled to transcriptional repression or activation. Unique phosphorylation events allow SRs to associate or disassociate with specific cofactors that may include pioneer factors and other tethering partners, which specify the resulting transcriptome and ultimately change cell fate. The impact of PTMs on SR action is particularly profound in the context of breast tumorigenesis, in which frequent alterations in growth factor-initiated signaling pathways occur early and act as drivers of breast cancer progression toward endocrine resistance. In this article, with primary focus on breast cancer relevance, we review the mechanisms by which PTMs, including reversible phosphorylation events, regulate the closely related SRs, glucocorticoid receptor and progesterone receptor, allowing for precise biological responses to ever-changing hormonal stimuli.",
keywords = "Breast cancer, Glucocorticoid receptor, Modification, Phosphorylation, Posttranslational, Progesterone receptor, Protein kinases, Signal transduction, Steroid hormones",
author = "Leehy, {Katherine A.} and {Regan Anderson}, {Tarah M} and Daniel, {Andrea R.} and Lange, {Carol A} and Ostrander, {Julie H}",
year = "2016",
month = "4",
day = "1",
doi = "10.1530/JME-15-0322",
language = "English (US)",
volume = "56",
pages = "R99--R114",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "3",

}

TY - JOUR

T1 - Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer

AU - Leehy, Katherine A.

AU - Regan Anderson, Tarah M

AU - Daniel, Andrea R.

AU - Lange, Carol A

AU - Ostrander, Julie H

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Steroid hormone receptors (SRs) are heavily posttranslationally modified by the reversible addition of a variety of molecular moieties, including phosphorylation, acetylation, methylation, SUMOylation, and ubiquitination. These rapid and dynamic modifications may be combinatorial and interact (i.e. may be sequential, complement, or oppose each other), creating a vast array of uniquely modified receptor subspecies that allow for diverse receptor behaviors that enable highly sensitive and context-dependent hormone action. For example, in response to hormone or growth factor membrane-initiated signaling events, posttranslational modifications (PTMs) to SRs alter protein–protein interactions that govern the complex process of promoter or gene-set selection coupled to transcriptional repression or activation. Unique phosphorylation events allow SRs to associate or disassociate with specific cofactors that may include pioneer factors and other tethering partners, which specify the resulting transcriptome and ultimately change cell fate. The impact of PTMs on SR action is particularly profound in the context of breast tumorigenesis, in which frequent alterations in growth factor-initiated signaling pathways occur early and act as drivers of breast cancer progression toward endocrine resistance. In this article, with primary focus on breast cancer relevance, we review the mechanisms by which PTMs, including reversible phosphorylation events, regulate the closely related SRs, glucocorticoid receptor and progesterone receptor, allowing for precise biological responses to ever-changing hormonal stimuli.

AB - Steroid hormone receptors (SRs) are heavily posttranslationally modified by the reversible addition of a variety of molecular moieties, including phosphorylation, acetylation, methylation, SUMOylation, and ubiquitination. These rapid and dynamic modifications may be combinatorial and interact (i.e. may be sequential, complement, or oppose each other), creating a vast array of uniquely modified receptor subspecies that allow for diverse receptor behaviors that enable highly sensitive and context-dependent hormone action. For example, in response to hormone or growth factor membrane-initiated signaling events, posttranslational modifications (PTMs) to SRs alter protein–protein interactions that govern the complex process of promoter or gene-set selection coupled to transcriptional repression or activation. Unique phosphorylation events allow SRs to associate or disassociate with specific cofactors that may include pioneer factors and other tethering partners, which specify the resulting transcriptome and ultimately change cell fate. The impact of PTMs on SR action is particularly profound in the context of breast tumorigenesis, in which frequent alterations in growth factor-initiated signaling pathways occur early and act as drivers of breast cancer progression toward endocrine resistance. In this article, with primary focus on breast cancer relevance, we review the mechanisms by which PTMs, including reversible phosphorylation events, regulate the closely related SRs, glucocorticoid receptor and progesterone receptor, allowing for precise biological responses to ever-changing hormonal stimuli.

KW - Breast cancer

KW - Glucocorticoid receptor

KW - Modification

KW - Phosphorylation

KW - Posttranslational

KW - Progesterone receptor

KW - Protein kinases

KW - Signal transduction

KW - Steroid hormones

UR - http://www.scopus.com/inward/record.url?scp=84969138547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969138547&partnerID=8YFLogxK

U2 - 10.1530/JME-15-0322

DO - 10.1530/JME-15-0322

M3 - Review article

VL - 56

SP - R99-R114

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 3

ER -